ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInSponsored Education from ACCC Corporate PartnersACCC eLearning LogInPresentations & Abstracts
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

CMS Interim Final Rule 2 COVID-19 Response: Telehealth

May 8, 2020

CMS Interim Final Rule 2 COVID-19 Response: Telehealth

By Teri Bedard, BA, RT(R)(T), CPC

On April 30, 2020, the Centers for Medicare and Medicaid Services (CMS) issued a second Interim Final Rule in response to the COVID-19 pandemic. This ruling adds to and changes many of the recent expansions and waivers of the provisions previously outlined by CMS since the Public Health Emergency (PHE) was initiated.

The CMS Interim Final Rule 2 is located in its entirety online. Below is a summary of the finalized changes as they apply to the provision of telehealth. Note that due to the rapidly changing response to the PHE, modifications could be released by CMS that may impact or change regulations contained within this summary.

Telehealth Expansion Update

In response to stakeholder feedback to CMS related to the initial Interim Final Rule released on March 30, 2020, CMS has made additional adjustments to telehealth and telehealth services available during the public health emergency (PHE). Stakeholders noted they are predominantly providing evaluation and management (E/M) services by telephone only. This is due to very few Medicare beneficiaries having the technology to do a visit with video capabilities or refusing to participate in a visit with video capabilities.

The use of telephone visits is replacing care that CMS would otherwise expect to be in-person or by the defined telehealth visit requiring audio-video capability. Due to this, CMS indicated the audio-only or telephone E/M visits should be considered telehealth visits and added them to the list of Medicare telehealth services for the duration of the PHE. CMS also noted the use of billing or telephone visits are only to be used for medical discussions. They are not to be used for administrative or other non-medical discussions with the patient. In addition, these visits still have cost-sharing obligations, meaning there may be a copay for the patient for each visit depending upon payer guidelines.

To account for the application of the telephone or audio-only visits, CMS has adjusted the Relative Value Units (RVUs) assigned to CPT® codes 99441-99443. Codes 98966-98968 are used by practitioners who cannot independently bill for E/M visits. These codes are not used in place of the outpatient office visits, so the RVUs assigned by CMS have not been adjusted.

The updated RVU values crosswalk from the established values for codes 99212-99214 for both Work and Direct Practice Expense. The values for Direct Practice Expense will crosswalk as follows: 99212 to 99441, 99213 to 99442, and 99214 to 99443. The values of Work RVUs for the duration of the PHE for the audio-only codes are as follows: 99441 = 0.48, 99442 = 0.97, and 99443 = 1.50.

CMS also indicated in the Interim Final Rule 2 that they would be adjusting how codes are added to the telehealth list in response to the PHE. CMS stated they believe the table, as adjusted over the last two interim final rules, reflects the majority of services that would be appropriate to bill for services provided to Medicare beneficiaries during the PHE. There may be other services over the duration of the PHE which may need to be added related to infection control, patient safety, and other public health concerns. In the event new services need to be added, CMS is implementing a new practice that does not involve notice and comment rulemaking. Instead, a sub-regulatory process to modify the list of telehealth services will be conducted.

CMS has published a list of services payable under the Medicare Physician Fee Schedule when furnished via telehealth. It is important to note that there are only a handful of codes that are considered telehealth that can be provided by audio-only.

Using Time to Select Appropriate Level of Telehealth Visit

Stakeholders submitted comments to CMS regarding the ability to use time as the basis for outpatient office E/M visits as part of the initial Interim Final Rule. CMS indicated in the initial ruling that the times, as identified in the CMS public use files, were the values to use; however, the values are not the same as those in the CPT® definitions for codes 99201-99215. CMS agreed these discrepancies can be confusing. CMS is implementing, for the duration of the PHE, the use of the typical times associated with the levels of the outpatient office E/M codes as established as part of the CPT® definition.

CMS is also clarifying, per the initial Interim Final Rule, when using time for the selection of the appropriate level of visit, the time is defined as all of the time associated with the E/M on the day of the encounter. All of the requirements for documenting the history and physical exam in the medical record do not apply for establishing the level of a telehealth provided visit.

Technical Charges for Hospitals Related to Telehealth Services

As part of this second Interim Final Rule, when a patient is in the hospital outpatient department and the physician is at a distant site, not somewhere else in the hospital, there may be a technical charge billable by the hospital. Since the hospital is using resources for the patient to access the real-time audio-video technology, the room, and staff resources, there are expenses to be accounted for by the hospital.

In these scenarios, a telehealth originating site facility fee would be paid by CMS to the hospital just as it would under telehealth services prior to the PHE. As part of the waiver, this is extended to the patient’s home as an originator site as well. Hospitals are reminded that services should only be provided to the patient in their home after the patient’s home is designated as PBD to the hospital for the provision of services. This would make the home an originator site and the location relative to the physician at a distant site, which is not in the hospital. Documentation of the service and location of the patient and physician are needed to support the telehealth visit provided.

Comments to Second Interim Final Rule

CMS is moving forward without delay the implementation of the finalized provisions in the second Interim Final Rule. The rules as outlined are retroactive to March 1, 2020. CMS is providing a 60-day public comment period that can be accessed at http://www.regulations.gov.

Additional Links to CMS Transmittals and Resources

There are several transmittals by CMS that also summarize and provide additional information for providers. The following links will take stakeholders directly to these transmittals:

  • Coronavirus Waivers & Flexibilities
  • COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers
  • Physicians and Other Clinicians: CMS Flexibilities to Fight COVID-19
  • Hospitals: CMS Flexibilities to Fight COVID-19
  • List of Telehealth Services

Teri Bedard, BA, RT(R)(T), CPC is the Director of Client Services at Revenue Cycle Coding Strategies LLC. In a previous blog post, Bedard answered questions about the details of the first CMS Interim Final Rule as it applies to the coverage of telehealth during the COVID-19 public health emergency. An archived webinar featuring Bedard further addresses the implications of the temporary CMS telehealth coverage decisions in response to the pandemic.

For resources on COVID-19 as it applies to the oncology community, visit ACCC’s continually updated Coronavirus Responsepage. ACCC members can also access ACCCExchange, a forum that allows them to communicate in real time with their colleagues about how the COVID-19 virus is affecting their communities and their patients.

Related Content

Addressing the In-Between: AYAs and Multifaceted Cancer TreatmentACCCBuzz Blog

Addressing the In-Between: AYAs and Multifaceted Cancer Treatment

Jenna Pierson

September 30, 2026

From Diagnosis to Survivorship: Understanding AML and CLL From End to EndACCCBuzz Blog

From Diagnosis to Survivorship: Understanding AML and CLL From End to End

Rachel Radwan

September 28, 2026

Upcoming Events

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual December 9, 2026 at 11:00 AM EST
Register Now!
2027 ACCC Leadership Summit

2027 ACCC Leadership Summit

In Person April 22, 2027 at 6:00 PM EDTWillard InterContinental Hotel, 1401 Pennsylvania Avenue Northwest, Washington, DC, USAWashington
Register Now!
DOS 2026 Fall Conference
Oncology

DOS 2026 Fall Conference

In Person Meeting & NetworkingNovember 19, 2026 at 5:30 PM EST215 Broadway N. Fargo, ND 58102Jasper Hotel, Fargo
Register Now!
RIOS Year-End Wrap-Up
Oncology

RIOS Year-End Wrap-Up

In Person Conference & ConventionDecember 1, 2026 at 6:00 PM EST1 Bannister Street, Providence, RI, USABrown University - Brown Faculty Club , Providence
Register Now!
NOS 2027 Official SABCS Review and Hematology Update
Hematology

NOS 2027 Official SABCS Review and Hematology Update

In Person Conference & ConventionFebruary 6, 2027 at 7:00 AM PST221 N Rampart Blvd, Las Vegas, NV, USAJW Marriott Las Vegas Resort & Spa, Las Vegas
Register Now!
ESHOS 2027 Official SABCS Review
Oncology

ESHOS 2027 Official SABCS Review

In Person Meeting & NetworkingFebruary 27, 2027 at 7:00 AM EST205 Lakeshore Dr, Canandaigua, NY 14424, USAHotel Canandaigua, Tapestry Collection by Hilton, Canandaigua
Register Now!
WAHO ASH Highlights & Insights
Oncology

WAHO ASH Highlights & Insights

In Person Conference & ConventionFebruary 27, 2027 at 7:00 AM CST1 West Dayton Street, Madison, WI, USAThe Madison Concourse Hotel, Madison
Register Now!
IOS 2027 Spring Hematology Conference
Hematology

IOS 2027 Spring Hematology Conference

In Person Conference & ConventionMarch 6, 2027 at 8:00 AM CST1000 Walnut St, Des Moines, IA, USAHotel Fort Des Moines, Curio Collection by Hilton, Des Moines
Register Now!
NCOA 2027 Annual Conference
Oncology

NCOA 2027 Annual Conference

In Person Conference & ConventionMarch 6, 2027 at 12:00 PM EST201 Harrison Oaks Blvd, Cary, NC 27513, USAEmbassy Suites by Hilton Raleigh-Durham/Research Triangle, Cary
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Addressing the In-Between: AYAs and Multifaceted Cancer Treatment

Addressing the In-Between: AYAs and Multifaceted Cancer Treatment

From mental health concerns to fertility preservation, adolescents and young adults with cancer require a specialized approach to treatment and survivorship care. In honor of Childhood Cancer Awareness Month, ACCC highlights a pivotal program from the University of North Carolina Lineberger Comprehensive Cancer Center and resources that meet the critical needs of these patients.

From Diagnosis to Survivorship: Understanding AML and CLL From End to End

From Diagnosis to Survivorship: Understanding AML and CLL From End to End

In recognition of Leukemia and Lymphoma Awareness Month, ACCC compiled a group of resources to help care teams navigate two of the most commonly diagnosed adult leukemias: acute myeloid leukemia and chronic lymphocytic leukemia.

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes
ACCCBuzz Blog

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes

Jenna Pierson; Gabrielle Stearns

September 25, 2026

ACCC’s Comments on the 2026 CMS Interim Final RuleACCCBuzz Blog

ACCC’s Comments on the 2026 CMS Interim Final Rule

Rachel Radwan

September 24, 2026

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than TechnologyACCCBuzz Blog

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than Technology

September 10, 2026

Highlights From Volume 41, Number 4 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 4 Oncology Issues

Gabrielle Stearns

August 20, 2026

Transforming Access to Care Through Pre-Intake NavigationACCCBuzz Blog

Transforming Access to Care Through Pre-Intake Navigation

Rachel Radwan

August 6, 2026

An APP-Led Outpatient Bispecific Antibody ClinicACCCBuzz Blog

An APP-Led Outpatient Bispecific Antibody Clinic

Rachel Radwan

August 4, 2026

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes

An at-home option for cervical cancer screening breaks down barriers to care and offers the same level of precision as screening in the clinic.

ACCC’s Comments on the 2026 CMS Interim Final Rule

ACCC’s Comments on the 2026 CMS Interim Final Rule

On June 1, 2026, CMS published its interim final rule (IFR), Medicaid Program; Community Engagement Requirement for Certain Individuals in the Federal Register, followed by a public comment period, during which time ACCC submitted a comment letter requesting amendments to the IFR.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Bringing CAR T-Cell Therapy to the Community Setting - Mini Podcast [Ep. 242]

Embedding Local Expertise in Rural Cancer Prevention - Podcast [Ep. 241]

From Reactive to Proactive: Improving Access to Cancer Care Through Pre-Intake Navigation - [Podcast] Ep. 240

Real-World Oncology Decentralized Trials - [Video Podcast] Ep. 66

View All Podcasts

Latest from Oncology Issues

August 2026
August 2026
June 2026
April 2026
February 2026
December 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login